British drugmaker AstraZeneca Plc said that it's Covid-19 vaccine should be effective against the new coronavirus variant and added that studies were under way to fully probe the impact of the mutation. "AZD1222 (AstraZeneca's vaccine candidate) contains the genetic material of the SARS-CoV-2 virus spike protein, and the changes to the genetic code seen in this new viral strain do not appear to change the structure of the spike protein," Reuters quoted AstraZeneca representative as saying in an email.from IndiaTV India: Google News Feed https://ift.tt/34CP5Va
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.